Aadhavan Laboratories is an integrated life sciences and pharmaceutical company offers solutions across the life sciences products value chain. Company engaged in world-class pharmaceuticals APIs, intermediates, impurities and R&D services to worldwide pharmaceuticals.
Aadhavan Laboratories established in 2020, mainly focuses on development of APIs, Life sciences products, APIs impurities, peptides and formulations of same. Aadhavan Laboratories, an ISO 9001:2015 certified organization is a well-informed, resourceful, promptly functioning competitive sourcing entity.

It involves in sourcing of pharmaceutical products (APIs, intermediates and impurities) and healthcare products. We offer wide range of product portfolio in pharma and healthcare products. We conglomerate customer’s requirement and proficiency with our processes to deliver sourcing solutions to our customers.

  • Large manufacturing facilities tie ups approved by regulatory bodies.
  • Enormous diversified product portfolio
  • R&D facility in India for active ingredients and for formulations
    (future investment).

Research & Development

Our own Research and Development section is continuously making efforts to improve our products and is equipped to develop new product in collaboration and as per our customer's demand and requirement. Over the years, we have widened the horizon of R & D and have extended its capabilities to manufacture new generation pharma raw materials.

Our Mission

Being a leading organization, we have set a certain mission for us that help us in earning a special niche in the industry. These are :
To serve the mankind by integrating sky scrapping quality to our products and services
To achieve our business objectives and goals through ethical means

Our Goal

Our goal is to achieve the fastest solution towards development of API’s, life sciences products and become a leader to improve the lives of people across the world.

Our Capabilities

  • Proficiency to synthesize API’s (Active Pharmaceutical Ingredients), pharmaceutical intermediates and related impurities in approved facilities in India, along with submission of technical documentation as required for Drug Master File (DMF) filing.
  • Support the requirement of technical documentation required by regulatory authorities.
  • Unconventional or patent non infringing routes in APIs synthesis.
  • Formulation facility creation is under progress.